Explore All 3116 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 2, 2017 |
| Target | PGXL Laboratories |
| Sector | Life Science |
| Buyer(s) | Prescient Medicine |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Life Science |
Prescient Medicine is a predictive health intelligence company. Prescient Medicine powerful tests and analytic solutions offer deeper predictive insights so doctors and patients have the data they need to make better, more informed clinical decisions, leading to the best possible patient outcomes. Prescient Medicine was established in 2014 and is based in Hummelstown, Pennsylvania.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science | 1 of 2 |
| Type: Add-on Acquisition | 1 of 2 |
| State: Kentucky | 1 of 1 |
| Country: United States | 1 of 2 |
| Year: 2017 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-23 |
AutoGenomics
Carlsbad, California, United States AutoGenomics, Inc. developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers. AutoGenomics' molecular diagnostics proprietary technology platform is in use globally in clinical reference laboratories, contract research organizations (CROs), specialty clinics and hospital laboratories. |
Buy | - |
